Company Filing History:
5 out of 320 
3 out of 11 
1 out of 435 
Years Active: 2023-2025
Title: Heike Kluth: Innovator in Transdermal Therapeutic Systems
Introduction
Heike Kluth is a prominent inventor based in Ochtendung, Germany, recognized for his contributions to the field of transdermal therapeutic systems. With a total of five patents to his name, Kluth has made significant advancements in the administration of guanfacine, a medication primarily used for the treatment of attention deficit hyperactivity disorder (ADHD) and hypertension.
Latest Patents
Among Heike Kluth's notable inventions are two innovative patents focusing on the transdermal delivery of guanfacine. The first patent involves a transdermal therapeutic system comprising a guanfacine-containing layer structure that includes a backing layer and a guanfacine-containing layer featuring at least one polymer and at least one additive. The second patent also centers on a transdermal therapeutic system for administering guanfacine, this time utilizing a silicone polymer within the guanfacine-containing layer structure.
Career Highlights
Heike Kluth has had a successful career working with various prestigious companies. Notably, he has been affiliated with LTS Lohmann Therapie-Systeme AG, where he contributed to the development of innovative therapeutic systems. He also spent time at DDP Specialty Electronic Materials US 9, LLC, further enhancing his expertise in the field of transdermal delivery technologies.
Collaborations
Throughout his career, Kluth has collaborated with talented professionals, including Marco Emgenbroich and Elke Klein. Their combined efforts have led to advancements in research and development, pushing the boundaries of transdermal therapeutic systems.
Conclusion
Heike Kluth stands out as a leading inventor in the healthcare industry, particularly in the realm of transdermal therapeutic systems. His groundbreaking patents and collaborative projects underscore his commitment to innovation and improving patient care through advanced medication delivery methods. As he continues to develop new solutions, Kluth's impact on the field remains significant, promising further advancements in healthcare technology.